Usana Health Sciences (USNA) Cash from Financing Activities (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Cash from Financing Activities data on file, last reported at -$3.6 million in Q2 2026.

• On a quarterly basis, Cash from Financing Activities rose 74.83% year-over-year to -$3.6 million in Q2 2026; TTM through Apr 2026 was -$29.8 million, a 523.45% decrease from a year earlier, with the FY2026 full-year figure at -$40.6 million, down 525.03% from the prior year.
• Cash from Financing Activities for Q2 2026 stood at -$3.6 million, down from $13.5 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for USNA reached as high as $22.9 million in Q4 2024 and fell as low as -$122.4 million in Q1 2022.
• Historically, Cash from Financing Activities has averaged -$11.2 million across 5 years, with a median of -$2.3 million in 2023.
• Across the five-year window, Cash from Financing Activities sank 26356.82% in 2023 and surged 3384.8% in 2024, its largest moves.
• Year by year, Cash from Financing Activities stood at -$150000.0 in 2022, then soared by 538.67% to $658000.0 in 2023, then jumped by 3384.8% to $22.9 million in 2024, then slumped by 104.27% to -$979000.0 in 2025, then tumbled by 271.91% to -$3.6 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$3.6 million in Q2 2026, $13.5 million in Q1 2026, and -$979000.0 in Q3 2025.